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ABSTRACT 
Basic molecular and cell research, production of recombinant proteins, diagnostic detection of 
genetic mutations, construction of nanostructures and high-throughput DNA sequencing are only 
a few examples of the diverse set of applications that are amenable thanks to the availability of 
synthetic DNA polymers in biomedicine.  
Strategic investments and technical progress together with the introduction of automation in the 
synthesis of DNA oligomers enabled to transform, in just a few decades, a process mastered only 
by a niche of biochemists into an affordable and available custom-made product to every scientific 
field.  
Despite such progress, innovation soon reached a plateau due to intrinsic limitations of the 
synthesis process, putting a barrier at two hundred nucleotides as the maximum length of synthetic 
DNA molecules. In the meanwhile, molecular biologists closed the gap thanks to a better 
understanding of polymerases and the mastering of directed evolution protocols making it possible 
to redesign processes that are more similar to what happens in nature, taking advantage of existing 
and improved enzymes for the generation of long and high-quality DNA molecules. This enabled 
to find novel applications for DNA such as gene editing or information storage.  
In this thesis I focused on the enzymatic production and functionalization of single stranded DNA. 
More specifically, in paper I we directed our attention to optimize the protocol for the templated 
enzymatic synthesis of oligonucleotides. We highlighted possible limitations of the technique and 
proposed a solution in employing a single stranded binding protein greatly decreasing double 
stranded DNA contaminants.  
In paper II we further extended the workflow. In here, we focused on continuing the previous 
protocol to accommodate the production of chimeric DNA-protein molecular tools needed in 
nanotechnology where DNA is considered more a building material rather than an information rich 
polymer while the actuation of a particular function is operated by proteins. We worked on a 
minimal bacteria-derived self-tagging domain that has the capacity to establish a covalent bond 
with a specific DNA sequence and some applications are suggested. Paper III represents the natural 
extension of this work even if, in this specific case, the earlier presented rational is reverted. More 
specifically, a biosensor for the detection of aquatic microorganisms was produced with the 
characterized bioconjugation technique where the chimeric protein was used as recognition moiety 
and the oligonucleotide as signal amplification device through its intrinsic DNAzyme activity.  
Finally, in Paper IV, we decided to use all the previously gathered knowledge – enzymatic DNA 
production and bioconjugation techniques – to conceive a novel basic biology investigation tool 
for the study of spatial organization of proteins. Here we took advantage of the possibility to grow 
a localized and unique DNA polymer with the ability to target proteins with DNA-protein chimeras. 
The resulting product is then recovered and decoded by next generation sequencing.   
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1 INTRODUCTION 
 
DNA is an information-rich polymer1 common to living organisms and made upon the 
repeating monomers, the nucleotides: made of a 2-deoxyribose sugar, a purine base - adenine 
(A) or guanine (G) - or a pyrimidine base - thymine (T), cytosine (C) - and a phosphate group2 
(Figure 1) As suggested by Phoebus Levene in 19193, a polynucleotide is a directional polymer 
made of those nucleotides that are connected between the fifth carbon atom of a nucleotide 
with the third carbon atom of the following nucleotide through phosphodiester bonds by the 
phosphate group. This nitrogen and phosphorous rich biomolecule was isolated for the first 
time at the end of the nineteenth century by the Swiss physician Frederich Miescher4 and 
twenty years later Albrecht Kossel identified the five nucleobases5. It is only by the middle of 
the twentieth century that enough knowledge6,7 was accumulated to obtain a more complete 
picture about its function and structure8. Understanding how DNA is organized also promptly 
suggested how molecular mechanisms work enabling a secure propagation of the genetic 
information.  
 
 
 
“It has not escaped our notice that the specific pairing we have postulated 
immediately suggests a possible copying mechanism for the genetic material.” 
Watson, J. D. & Crick, F. H. C., 1953 
 
 
 
In nature, DNA is mostly found in its double stranded forms where two complementary 
filaments interacting through base pairing and stacking are directed toward opposite directions 
forming an antiparallel polymer8. Nevertheless, it is also possible to find organisms that make 
use of single stranded DNA (ssDNA)9,10 and even in higher eukaryotes, the double stranded 
genomic DNA can take advantage of ssDNA structures as, for example, regulatory elements11.  
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Figure 1. Structure of nucleosides and features of a single-stranded polynucleotide. DNA 
in its single stranded form exhibits a peculiar elastic behavior that is of major relevance for 
biological and non-biological processes. Such molecule forms secondary structures as a 
consequence of canonical Watson-Crick hydrogen bonding and other non-ordinary base 
paring.   
Synthetic ssDNA, in vitro, is an extremely versatile molecule that can be exploited for a wide 
range of applications. Despite being rather fragile, it enables an unprecedented control over the 
possibility to position molecules in space with a nanometer precision when used as a 
construction material in nanotechnology12. Moreover, chemicals moieties and proteins 
connected to ssDNA can be organized with great precision13. Taking advantage of strand 
complementarity, ssDNA can also be designed to interact with genomic sequences or 
messenger RNA14. Furthermore, the selection of specific primary structures of a polynucleotide 
that could be generated rationally or combinatorically, is also responsible for the formation of 
intramolecular secondary structures, known as aptamers15, able to interact with more complex 
players, such as proteins16. Selection and evolution methods17 of specific structures enable the 
possibility to discover nucleic acids able to execute enzymatic-like processes18 or behave like 
fluorescent molecules19.  
Another important aspect that makes ssDNA an attractive molecular tool, is the possibility to 
produce it in large amounts with different technologies and platforms at competitive prices. 
Herein the methods for production and functionalization of ssDNA will be briefly described 
while the stress will be put on selected applications in the enclosed papers of this thesis.  
 
1.1 METHODS FOR THE PRODUCTION OF ssDNA 
There are essentially three main strategies for the production of synthetic DNA. The method 
that dominates the market is the chemical synthesis on solid-phase but its intrinsic limitations 
drove the development of alternative strategies using enzymes in vitro or even taking advantage 
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of the molecular machinery of living organisms. The following table summarizes the main 
methods discussed in this thesis (Table 1).  
 
 
Table 1. Direct comparison of some of the most representative ssDNA production methods 
discussed in this thesis.  
 
1.1.1 Chemical synthesis 
Oligonucleotides have been synthetized in solution from the 1950s20. The synthesis method 
rapidly evolved, and a more efficient reaction, based on the phosphoramidite chemistry21, was 
implemented on solid-phase in columns. 
The opportunity to easily synthesize nucleic acid polymers made it possible to understand many 
different molecular processes that occur in a cell, further testifying the complementarity need 
and importance of chemistry and biology. Among the most important milestones achieved at 
the early stage of such technology, we have the deciphering of the genetic code22 and the 
synthesis of the first synthetic gene encoding for the somatostatin hormone in Escherichia 
coli23. Moreover, the introduction of automation in the synthesis process was fundamental to 
reach a cost-effective scalable production of oligonucleotides, up to 96 or even 384 at the same 
time, in the synthesis scale ranging from 10 to 100 nmol24. 
Nevertheless, solid-phase column based synthesis of oligonucleotides is affected by limitations 
with respect to lengths and fidelity25,26. In fact even if the reaction yield of each cycle is rather 
high, more than 99% per coupling cycle, this will result in a final 13% yield for a desired 200 
nucleotide oligo27. Length of the desired oligonucleotide is not the only problem, as also sudden 
cleavage of the polymer could happen during the deprotection step. Still connected with this 
step, another common problem is single base deletion. For all these reasons, a purification step 
of the aimed product is always advisable when long oligonucleotides are desired. Recent 
progress in the production steps will soon be translated in better commercially available 
oligonucleotides28 and some companies have already extended the maximum length of 
oligonucleotides to 300-400 bases29,30. 
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A further improvement in the industrial process is exemplified by the development of array-
based oligonucleotides synthesis. DNA printing was first achieved with the use of 
photoactivated deprotection of the phosphoroamidite chemistry31. The invention of microarray 
enabled to reduce the synthesis scale, thus reducing the synthesis costs down to $0.0001 - 
$0.00001 per nucleotide depending on the platform used and the oligonucleotide 
characteristics, whereas the price for column synthesized oligos still ranges from $0.05 to $0.10 
per base32. For these reasons, oligonucleotide pools are now the preferred starting material for 
gene synthesis even if the concentration of every oligo is really low.  
A major difference between chemical synthesis of ssDNA and the other proposed methods is 
the possibility to grow a polymer in an untemplated fashion while, most of the enzymatic 
protocols, such as the asymmetric PCR method, rely on a sequence-verified DNA template to 
be further propagated. The exception to this rule is represented by those methods based on the 
activity of the enzymes like terminal deoxynucleotidyl transferase (TdT) or similar52.   
1.1.2 Enzymatic synthesis 
Synthetic biochemistry is not the only discipline that enabled to produce high-quality 
oligonucleotides. In fact, molecular biologists soon understood that polymerases provide a 
much higher fidelity in DNA synthesis. The error rate of chemical synthesis is between 
1 × 10−2 and 1 × 10−4 according to the method used27, while enzymatic synthesis in vitro has 
reported an error rate of 1 × 10−5 to 1 × 10−6 33,34 and this without cells proofreading 
machineries.  
Since the development of the polymerase chain reaction (PCR) with thermostable enzymes35 it 
was immediately clear that such method is much more practical, if a template sequence is 
available. Taking advantage of those findings a series of enzymatic strategies have been 
developed and optimized. The first reported approach for the production of a ssDNA molecule 
of interest, is an asymmetric PCR36–38. In this protocol, the proportion of primers used in the 
reaction is strongly unbalanced enabling a favorited synthesis of one strand over the other. 
Even if effective, this approach remains imprecise and requires a purification step as point 
mutations are amplified during each round. Similar approaches take advantage of 3’ protected 
oligonucleotides and enzymatic clean-up through exonuclease treatment of the unprotected 
strand39. In alternative to exponential amplification, other protocols are based on a linear 
amplification taking advantage of naturally occurring ssDNA producing polymerases such as 
Φ29 during the rolling circle amplification (RCA)33,40,41. Such strategies have been extensively 
used to amplify genomic DNA for sequencing purposes42, DNA and RNA detection43–45 but, 
most importantly, it has been used for high quality ssDNA production within the monoclonal 
stoichiometric method (MOSIC)46,47. Notably, the production of ssDNA for the MOSIC 
protocol can also take place in biological systems such as bacteriophages. Other variants of the 
technique48 aimed to remove the enzymatic restriction step and rather relied on autocatalytic 
deoxyribozymes in presence of metal ions thus reducing the freedom in the choice of the 
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sequence to produce49. Other approaches seem achievable with new molecular tools such as 
modified versions of the CRISPR-Cas9 system but have never been exploited for this 
purpose50. An alternative and more recent approach is based on the usage of the enzyme 
terminal transferase in combination with adapted nucleobases51,52. 
The unmet need for the market of long ssDNA with high degree of purity motivated the 
investments53 in this field leading to the foundation of several startups such as DNAscript54, 
Nuclera55, Evonetix56 and Moligo Technologies57.  
1.1.3 In vivo synthesis 
A more recent approach is based on the exploitation of the life cycle of ssDNA phages. In this 
case, the sequence of interest, embedded in a plasmid characterized also by the presence of a 
bacteriophage specific packaging consensus sequence, is propagated in phage-competent 
bacteria in a bioreactor58,59. The method aims primarily to permit an agile scale-up enabling 
gram-scale production of ssDNA and has been developed mainly in the field of DNA 
nanotechnology but greatly limits the sequence freedom of choice. A few attempts of producing 
ssDNA60–62 in eukaryotic cells for therapeutic purposes have been documented in the past but 
little or no follow-up studies have been published.  
 
1.2 OLIGONUCLEOTIDES-PROTEINS CONJUGATION METHODS 
Even if DNA offers the unprecedented ability to program the assembly of nanostructures at the 
nanoscale or enables precision molecular detection operations with a large degree of control 
that is unreachable by any other molecule, the amount of operations carried by naked DNA are 
limited. For this reason, most of the applications of ssDNA in nanotechnologies rely on a 
multitude of biomolecule conjugates to obtain the desired outcome13,63,64.  
Conjugation represents the best possible way to increase the functionality of nanostructures. 
Many molecules have been coupled to DNA oligonucleotides such as lipids65, drugs66,67 and 
even chemical libraries68. But hereon we will mainly focus on protein conjugates69.  
Despite the availability of several different approaches70–73 (Figure 2) achieving a successful 
DNA-protein conjugate remains a pitfall-prone process that is highly protein dependent and 
that requires optimization for each new conjugate. Over-conjugation, target protein loss of 
function or low reaction yield represent common problems. Two main conjugation approaches 
intended to overcome the previously highlighted limitations will be introduced here. 
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Figure 2. Main protein bioconjugation strategies discussed in this work. 
 
1.2.1 Self-labeling tags 
To avoid the above mentioned issues, conjugation strategies based on genetically encoded self-
labeling tags, have been recently developed to enable a reproducible site specific labeling of 
the target proteins74,75. Nevertheless, for any of these common strategies (SNAP tag, HALO 
tag), as it happens to the protein as well, the DNA molecule of interest needs to be chemically 
modified – a process that is only feasible when starting out with synthetic DNA 
oligonucleotides in vitro. 
Aiming for an automated system that enables self-assembly and functionalization through 
protein conjugation in physiological conditions is a challenging task for most of the listed 
strategies while, rather than DNA, the most successful orthogonal approaches are directed to 
functionalize proteins76,77. As previously mentioned, it has been reported that there is the 
possibility to produce ssDNA in eukaryotic cells60–62. Therefore, the possibility to use 
genetically encoded self-tagged domain taking advantage of viral and bacterial proteins69,78 to 
covalently bind unmodified DNA becomes an attractive approach for the autonomous 
assembly of macromolecular complexes in living organisms. 
1.2.2 Copper-free click chemistry 
This relatively new approach is compliant with most of the earlier stated requirements for an 
efficient and biologically compatible reaction. The term was first introduced in 2001 by Barry 
Sharpless79 and became a very successful strategy to efficiently link biomolecules modules 
with high specificity and in aqueous environment. The set of reactions was expanded over time 
and the copper catalyst, that could be damaging for nucleic acids80, is not necessary to activate 
the alkyne if introduced in a strain-promoted destabilized form81.  
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Even though such class of reactions are fast, specific and efficient for bioconjugation, both in 
vitro and in vivo82,83, modifications of the biomolecules of interest are needed to introduce the 
moieties for the reaction to happen. For what regards nucleic acids, most suppliers provide in 
their catalogs84 at an extra cost the introduction of the desired modification while proteins 
require a supplementary effort to become compatible for such approach. The modifications 
could be made by introduction of unnatural amino acids85 or by a first, unspecific86 or site 
directed87, conjugation step with a divalent chemical handle.  
 
1.3 ssDNA AND ssDNA-PROTEIN CONJUGATE APPLICATIONS  
Since their introduction on the market, commercially available oligonucleotides have soon 
become affordable and indispensable instruments in the toolbox of molecular biologists. 
Nowadays DNA oligonucleotides are used in many other disciplines such as material sciences 
and data sciences88–91. 
Oligonucleotides have found applications in very diverse situations and for this reason it would 
not be possible to exhaustively list all of them but, for the purpose of clarity, it is possible to 
group the main uses of ssDNA into the following categories. 
1.3.1 Detection and / or amplification  
Historically, this is the first and main application of short oligonucleotides. This could be 
achieved using both enzymatic and non-enzymatic methods. Among the enzymatic methods 
we encounter the most popular protocol in molecular biology where a couple of 
oligonucleotides, in this case called primers, promote a targeted enzymatic amplification of a 
DNA sequence via polymerase chain reaction (PCR)92 by thermal cycling that could be used 
for both preparative and analytical purposes.  Since then, new enzymes have been produced 
and protocols optimized according to specific needs. A second big family of enzymatic 
reactions is represented by isothermal amplification reactions. This last set of reactions is 
performed by a specific set of polymerases characterized by a strong strand displacement 
activity hence the reaction does not need a thermal induced denaturation between every new 
cycle. This specific activity connected with a circular template enables the rolling circle 
amplification (RCA). This very processive reaction has been extensively used for the purpose 
of amplifying the signal and being detected by hybridization but also for the generation of 
genomic DNA libraries for sequencing and for in situ sequencing applications when combined 
with the specific design of padlock probes that provide the amplification template. There are 
also other chimeric (enzymatic-non-enzymatic) reactions such as the loop mediated isothermal 
amplification (LAMP)99,100. 
Non-enzymatic methods have also been extensively used for the detection of nucleic acids. 
Those approaches are primarily based on classical Watson-Crick base pairing93,94. 
Oligonucleotides could be intrinsically fluorescent, radio-labeled or modified with small 
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molecules such as biotin or digoxigenin for immuno-based assays. These techniques are widely 
applied when it comes to decipher gene expression profiles, when labeled molecules are 
hybridized to synthetic oligonucleotides printed on microarrays but also to detect messenger 
RNA in situ. Lately such techniques have been further implemented and the detection of even 
weak signals is guaranteed by nucleic acids self-assembly such as the hybridization chain 
reaction (HCR) 101 or RNAScope® commercial system. The first method is based on 
oligonucleotides forming metastable hairpin structures that, once triggered with an initiator 
strand, are able to grow linear polymers made of fluorescently labeled oligonucleotides. The 
second method instead is based on a less dynamic assembly of labeled oligonucleotides 
following a “Christmas tree”-like scheme. Recently, labeled oligonucleotides have also been 
used as super resolution microscopy probes.103,104. 
A less canonical use of nucleic acids is as a detection tool of proteins or small molecules 15,95. 
This could be achieved by a direct interaction of the oligonucleotide secondary structure, when 
a so called aptamer96 is used, or by an indirect interaction when the nucleic acid handle is 
conjugated to a protein such as an antibody (discussed in further details in section 1.3.4). 
1.3.2 Nano-construction material  
ssDNA is extensively used for the production of nanostructures105. Such devices can be 
assembled from a rationally designed pool of oligonucleotides to form bidimensional106 or 
tridimensional structures107. The easy access to short oligonucleotides enables the design of 
nanostructures upon a given sequence of the ssDNA from different sources such as the genome 
of bacteriophages108. To enable the compaction of DNA strands (“scaffold” and “staples”) a 
saline buffer containing magnesium is used. DNA nanostructures can be folded thanks to direct 
complementarity of the sequences in a temperature ramp protocol. New generations of 
structures are less packed thus require less salts in the buffer for a successful folding107. 
Nanostructures can be folded naked or functionalized with chemicals or proteins to execute 
specific tasks109. Other than rationally designed nanostructures, DNA can be used to form 
hydrogels and matrices by RCA reaction110.        
1.3.3 Therapeutics, genome editing and gene assembly 
A growing application field of ssDNA is the development of therapeutic protocols thanks to 
the ability to design with precision macromolecules able to target cells at different levels such 
as transcription, RNA splicing and gene expression. For example, DNA oligonucleotides and 
later chemically modified oligonucleotides have been used to disrupt putative transcription 
sites through the formation of triplexes111–113. Such macromolecules interact with the target 
sequence via either Watson-Crick base paring or form triple helices on polypurine stretches of 
DNA double helices via Hoogsteen or reverse Hoogsteen interactions. Despite the precision of 
such tools, synthetic oligonucleotides suffer from two main drawbacks: limited extracellular 
stability and difficult delivery. For those reasons, chemists developed several generations of 
modifications to improve oligonucleotides half-life, biodistribution and increase efficient 
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delivery to target cells114, without impairing the specificity toward the target but aiming to 
increase the desired disruptive activity115. More recently, ssDNA has also been used as donor, 
to template the desired mutations or de novo insertions of DNA in genome editing protocols 
using the CRISPR-Cas9 system116. Furthermore, what fits this section is the possibility to 
assemble genes from oligonucleotides pools for synthetic biology applications117. 
1.3.4 DNA assisted proteomics 
Many different methods have been developed over time for the detection of proteins and to 
highlight hypothesized protein-protein interaction. A classical thorough analysis workflow 
would require a multi-step approach. Following in vitro characterization, interactions would of 
course need to be validated in vivo as well. Additional needed steps for a full characterization 
require the study of the domains involved in the interaction. Moreover, functional assays need 
to be designed to understand the consequences of the interactions.  
The choice of the optimal technique to apply depends on the question that needs to be answered 
but also on the specific nature of the interaction. For example, a stable interaction can be best 
investigated by co-immunoprecipitation118 or far western methods119 while a transient 
interaction is more difficult to capture and could require a cross-linking step or label transfer 
method. Briefly, techniques could be organized into four different groups: 
● The main category is represented by the so-called “classical” biochemical approaches. 
Protein array120, co-immunoprecipitation, affinity chromatography121 and far western.  
● The other main category of “classical” approaches involves genetic manipulations such 
as the yeast-two hybrid system122, phage display123 and the expression of protein 
libraries.  
● Modern co-localization approaches are based on FRET124 and BRET125 methods and 
co-immunolocalization by microscopy.   
● Other main techniques that cannot find a place in these classes are: surface plasmon 
resonance126, X-ray crystallography127 and cross-linking128. 
Plasma membrane proteins (PMPs) have peculiar chemical and physical properties that make 
their study difficult, therefore a new set of methods, mainly low-throughput optical methods, 
have been developed. Each method guarantees a different spatial and temporal resolution 
power that has to be taken into account accordingly. For example, single-molecule fluorescence 
imaging129 and fluorescence correlation spectroscopy (FCS)130 have more or less the same 
spatial resolution (250 nm) but FCS has a superior temporal resolution and should be preferred 
for highly dynamic proteins. FRET instead, enables resolution down to 5-10 nm with diffracted 
limited acquisition systems. Other PMPs study methods aim to reduce membrane complexity 
and use synthetic and cell derived membranes to be probed with atomic force microscopy131 or 
other diffraction or non-diffraction limited microscopy methods such as DNA-PAINT132 that 
is based on antibody-oligonucleotide conjugates.  
In this context DNA became more and more popular as an additional tool for protein detection 
and identification133,134. The introduction of DNA to decode the proteome became attractive 
thanks to the technical improvement in the ability to sequence DNA with next generation 
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sequencing135. Among the implemented strategies involving DNA-antibody conjugates, a 
prominent microscopy-based technique is the so-called proximity ligation assay (PLA)43,45,136. 
Here the proximity of proteins of interest determine the assembly of a circular template for a 
localized RCA reaction. The RCA product is detected by hybridization with a fluorescently 
labeled complementary probe.  
To address the low throughput achieved so far, new proteomic methods have been recently 
published to study cell-type specific proteomes in vivo137 and proteins surrounding a protein of 
interest by biotin labeling 138. 
All the aforementioned techniques provide a lot of information about targets vicinity, but it is 
not yet possible to have an amplification template guaranteed by a greater number than two 
analytes. One such technique that enables an open detection of an undefined number of proteins 
locally constrained has not yet been described. 
Nevertheless, there is a growing interest in the establishment of a technique able to decipher 
the relations of proteins in constrained spaces as it is possible to have a bulk measurement on 
the protein presence in the cell and a fairly good idea of how the protein is organized but not 
totally conclusive yet139,140. Each and every method suffers from strong limitations and 
therefore makes it less appealing to a wide application.  
 
1.4 DECIPHERING MEMBRANE PROTEIN ORGANIZATION 
In all biological systems it is common to encounter the compartmentalization phenomenon141. 
This ability to develop specialized units with all the necessary components to accomplish 
specific tasks is oriented toward the overall increased efficiency of the cell’s biochemical 
machinery and represents a clear proof of the endosymbiotic theory142. Nature-inspired 
compartments re-created in vitro have also been used for the optimization of synthetic 
biochemical processes143.  
Cell-cell communication, signal transduction and integration are some of the functions that are 
made possible thanks to the organization of proteins in the plasma membrane (PM). PM is one 
of the major cell compartments and it is now clear that proteins are not simply distributed 
uniformly but they are highly organized according to the cell’s needs144.   
Since the 1970s a lot of theories about the organization of plasma membrane proteins (PMPs) 
have been developed and revised145. For the aim of this introduction it is possible to focus on 
different types of PM organization units according to their size extension. When a cell is 
polarized, the membrane is organized in obvious macrodomains that exhibit peculiar structures 
such as microvilli in small intestine epithelial cells. Other macrodomains are represented by 
podosomes and focal adhesions146 or immunological synapse in leukocytes cells147. Even if a 
sharp distinction is always difficult to make, other PM functional units are microdomains that 
range from a few micrometers to 100 nm usually induced by ligands13; such domains are 
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thought to be organized thanks to the PM lipid composition148 and proteins such as the arginine 
transporter can be found149. Another smaller PM unit is represented by nanodomains that have 
a size between 100 and 10 nm in which RAS proteins can be found150. Finally, nanoclusters 
have a size of a few nanometers such as GPI-AP clusters151.  
The clustering of PMPs has been described earlier145,152 and the reasons that could explain this 
phenomenon could be stretched beyond the fact of having specialized areas to execute specific 
tasks. As a matter of fact, clustering enables different proteins to interact and expose hidden 
domains that could trigger signaling pathways. On top of that, increasing the critical mass of 
receptors interacting with ligands could provoke a stronger signal cascade that would affect the 
cell behavior153,154.  
 
1.5 TOWARDS AN OPTICS FREE DNA-MICROSCOPY 
DNA-protein conjugation techniques enabled the generation of new powerful biological 
investigation tools that, among the other things, permitted a better understanding of protein-
protein interactions. However, the usage of such tools is framed in rigid and binary systems 
able to achieve only an all-or-none output and, most importantly, where the exact number of 
proteins within a cluster remains unclear. To gather such information, using a high throughput 
technique, biological detection devices should be re-designed taking advantage of an existing 
approach: DNA-encoded barcodes.  
Such method was already applied in pharmaceutical industry. In 1992, Sydney Brenner and 
Richard Lerner published a thought experiment that preconized DNA-encoded chemical 
libraries155 for combinatorial chemistry. Since then, some companies such as GSK156 and 
Vipergen157 have decided to embrace such technology bringing to light some interesting 
molecules. The concept has since been expanded and it is also possible to profile cells 
individual proteomes thanks to DNA-encoded antibody libraries68. DNA-encoded barcodes 
had become even more attractive thanks to the parallel development of cost-efficient high 
throughput sequencing methods158.  
Inspired by this approach, a breakthrough study attempted to reconstruct the connectome 
labeling each neuron with a different RNA barcode and collecting the fusion products of two 
barcodes in synapses159,160. In the specific case, Zador’s lab engineered a population of viruses 
to produce a specific protein with, on one hand, the ability to bind a randomized - barcoded - 
mRNAs intracellularly and, on the other hand, to be crosslinked to the same protein expressed 
from a neighboring cell. In such a way the crosslinked protein product brings to close proximity 
two unique short mRNAs that can be fused in a single molecule. In this case cell unique 
barcodes enable to reconstruct the connectome in a matrix.  
The ability to reconstruct the spatial organization of proteins or any other biomolecule of 
interest thanks to localized and unique DNA sequence barcodes would enable one to investigate 
even protein interactions and distribution on PM161–163. Toward this direction a new DNA 
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origami-made platform, called “nanoscope” by the authors, has been recently published164 but 
has not yet been used on biological samples.  
Today the generation of new tools to answer biological questions at the nanoscale represents 
an unmet need that could be achieved in the near future combining previously developed 
techniques. This would enable us to broaden our knowledge of basic molecular mechanisms of 
the living cell with an unprecedented throughput and resolution. 
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2 AIMS 
The works collected in this thesis aim to both explore the understanding of basic molecular 
mechanisms underlying single-stranded DNA amplification and enzymatic conjugation as well 
as applying such knowledge to the development of tools and methods for biological 
investigation at the nanoscale. 
Paper I: To investigate the causes and possible countermeasures of the generation of an 
unwanted – double stranded DNA – product in the generation of single stranded DNA via 
rolling circle amplification.  
Paper II: To take advantage of a naturally occurring enzymatic process in pathogenic bacteria 
to develop and optimize a novel DNA-protein conjugation method. 
Paper III: To implement a novel bio-sensing strategy with the use of a chimeric DNA-protein 
conjugate. 
Paper IV: To deliver a set of molecular tools and protocols for the study of protein clustering 
organization at the nanoscale enabling topological reconstruction via next generation 
sequencing without the need of microscopy. 
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3 MATERIALS AND METHODS 
Here some of the most relevant methods used in the appended works are introduced. A detailed 
explanation of relevant protocols and techniques are included in the manuscript section. 
3.1 ENZYMATIC PRODUCTION OF SSDNA (MOSIC) 
The production of unmodified oligonucleotides of different lengths was carried out with the 
method developed in our lab46, the so called MOSIC protocol. Briefly, the generation of an 
oligonucleotide of interest is ensured by the following steps: 
 1) The generation of a clonal template;  
2) The linear RCA amplification reaction in vitro; 
3) The enzymatic digestion and purification of the oligonucleotide of interest.  
3.1.1 Generation of RCA template 
A MOSIC template is generated either by a sequence verified clonal plasmid or 
oligonucleotides assembly. In the first case the plasmid containing the pseudogene template 
(BioCat) is harvested from a bacterial culture, digested to remove the unwanted features (i.e. 
antibiotic resistance, origin of replication) and the fragment of interest is re-ligated in a mini-
circle like template form using the T4 ligase (0.25 U/ µl, Thermo Scientific) in 1x rapid ligation 
buffer at 22 ºC for 2 hours. In the latter case, synthetic oligonucleotides (IDT) are circularized 
by hybridization to a bridging oligonucleotide (100 mM potassium acetate; 30 mM HEPES, 
pH 7.5) in a 1 to 1 ratio (1 µM for each oligonucleotide). Fifteen μL of such reaction are 
combined with 5 units of T4 ligase (Thermo Scientific) in a diluted ligation buffer (1:20) 
supplemented with 1 mM ATP. The twenty μL reaction is incubated at 22 ºC for 2 hours and 
the product of interest is purified first by enzymatic removal of unligated oligonucleotides with 
the addition of 1 μL of ExoSAP-IT (Thermo Scientific) and 1 μL of Exonuclease III (Thermo 
Scientific) for 30 minutes at 30 ºC and later by extraction from a 10% denaturing (8 M urea) 
polyacrylamide gel by diffusion in a 10 mM Tris-HCl pH 7.5 solution at 40˚ C for 16 hours 
and concentrated using the QuiaEX II kit (Quiagen) according to the manufacturer instructions. 
The MOSIC template sequence encloses the following features: one or more oligonucleotide 
template sequences interspaced by short self-folding sequences with the aim to generate a 
restriction site for enzymatic cleavage of the polymer. Moreover, the sequence hosts also a 
nicking site or hybridization target site for an oligonucleotide to prime the enzymatic 
amplification reaction.  
3.1.2 Linear RCA amplification 
The combination of the so-prepared template with a RCA amplification reaction mixture: Φ29 
polymerase (0.5 U/µl, Thermo Scientific), dNTPs (1 mM each, Thermo scientific) in a 1x Φ29 
reaction buffer 33 mM Tris acetate, 10 mM magnesium acetate, 66 mM potassium acetate, 0.1 
% (v/v) Tween 20 and 1 mM Dithiothreitol (DTT), Thermo Scientific) is then incubated at 30 
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ºC. Such reaction is known to generate a great amount of product in short time. When a high 
yield and purity of the product is paramount, a long reaction (12-16 hours) is supplemented 
with T4 gene 32 ssDNA binding proteins (100 ng/µl, NEB) to inhibit the formation of dsDNA 
products. The reaction is stopped with a denaturation step (20 minutes, 75 ºC). 
3.1.3 Enzymatic digestion and purification of the oligonucleotide of interest 
The so-generated ssDNA polymer is enzymatically digested at the “hairpins” site, with the use 
of a type IIs restriction enzyme BseGI - GGATG(2/0)^ (Thermo Scientific) or BtsCI165. The 
choice of this enzyme guarantees maximum freedom in the design of oligonucleotide 
sequences. The digestion reaction is carried out with a 1:100 dilution of the enzyme for 12 
hours at 50 ºC in 1x CutSmart (NEB) buffer. The degree of digestion and the purity of the 
desired oligonucleotide are assessed by a denaturing polyacrylamide gel (PAGE), 20% 
polyacrylamide, 20% formamide and 8 M urea dissolved in 1× TBE buffer. Nucleic acids are 
stained with SYBR® Gold (Thermo Scientific) and images are acquired using a Las 4000 
imager (GE). The oligonucleotide can be extracted directly from the gel by diffusion or used 
as is after a desalting/buffer exchange step in an Amicon spin filter (Millipore). 
3.1.4 Electrophoretic characterization of ssDNA 
Despite denaturing (8M Urea) PAGE gel represents the best option to characterize 
oligonucleotides, native agarose gel (2% or above), ethidium bromide stained, are used to 
highlight the formation of undesired dsDNA47. 
3.2 RECOMBINANT PROTEINS DESIGN, EXPRESSION AND 
CHARACTERIZATION  
The open reading frame encoding proteins expressed in this thesis were derived from NCBI 
Genes database or from the literature166–168. The coding sequence was optimized for the 
bacterial expression169 and synthetized as dsDNA fragment (IDT) or fusion products that were 
obtained by PCR. Such fragments were cloned in expression vectors, such as pET-16b, under 
the control of an IPTG inducible T7 promoter. For affinity purification purpose a 6 or 10 His 
tag was also added in frame at the C or N terminus of the recombinant protein. A small-scale 
production of the recombinant protein was expressed in E. coli BL21 pLyss and IPTG induced 
overexpression of the protein of interest was validated by SDS-PAGE. Large scale production 
and purification was carried out by the protein science facility (Karolinska 
Institutet/SciLifeLab).  
3.3 DESIGN OF MOSIC PSEUDOGENES AND OLIGONUCLEOTIDES FOR 
PROTEIN CONJUGATION 
In silico analysis of the sequence enabled to reduce secondary structures that might hinder or 
inhibit the conjugation yield. For this purpose, the prediction tool Nupack170 
(http://www.nupack.org) was used to evaluate the complexity of both synthetic 
oligonucleotides and MOSIC-produced oligonucleotides. The template design of MOSIC 
oligonucleotides was generated via the online tool available on our website 
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(http://www.hogberglab.net/software/). Oligonucleotides to be conjugated with the mVirD2 
tag were fused at the 5’ with the T1 target sequence69 while those to be used with click 
chemistry were ordered (IDT) with a 5’ azido moiety.  
3.4 DNA-PROTEIN CONJUGATION 
3.4.1 mVirD2 tag mediated conjugation of oligonucleotides 
The self-tagging domain mVirD2 was used alone or in fusion at the N terminus with other 
proteins for the sequence specific conjugation of an oligonucleotide. The conjugation reaction 
yields a site-specific conjugation product in biological conditions. Generally, protein and 
oligonucleotide are mixed at a 1:1 ratio in TKM buffer (50mMTris–HCl pH 8, 150 mM KCl, 
1 mM MgCl2, 10% glycerol) and incubated at 37 ºC for 1 to 2 hours in a PCR thermocycler. 
When using synthetic oligonucleotides, phosphorothioate bonds are introduced in the 
conjugation site to further increment the reaction yield69. 
3.4.2 Sortase A mediate conjugation of oligonucleotides 
This two-step protocol takes advantage of the Sortase A enzyme (SrtA)171. Such enzyme 
recognizes a specific peptide tag (LEPTGG) and has the ability to cut the polypeptide at the 
glycine position and fuse it to another protein substrate with a N terminus glycine. The 
introduction of a DBCO-amine compound (Sigma Aldrich) in the reaction enables the site-
specific modification of proteins for strain-promoted azide-alkyne cicloaddition81 with an azido 
modified oligonucleotide. Briefly, a reaction containing 50 μM of the recombinant affibody, 
150 μM of Sortase A and 10 mM of DBCO-amine (Sigma Aldrich) in Sortase A Buffer 
(HEPES 20 mM, NaCl 150 mM, CaCl2 10 mM) was incubated for 2.5 hours at 25˚ C. The 
conjugation product (affibody-DBCO) was purified flowing the crude reaction through a 
HisPur cobalt superflow agarose resin (Thermo Scientific) for 1.5 min at 1000 g. The coeluted 
DBCO-amine compound was removed using an Amicon® 3 kDa spin filter (Millipore). The 
conjugate was quantified with Bradford assay. The conjugation reaction was assessed in a Tris-
Tricine 16% gel (Novex). 
3.5 ELECTRO MOBILITY SHIFT ASSAY 
The degree of conjugation with the mVirD2 tag was assessed with native PAGE gels (a fresh 
solution comprising polyacrylamide (19:1) final concentration 10% (Biorad), 0.5x TBE buffer 
and glycerol (2.5%, v/v) was mixed and polymerized by the addition of fresh 10% APS 
solution, final concentration 10%, and TEMED, final concentration 1%, in a mini-protean gel 
system (Biorad). TBE 0.5x was used as running buffer and the gels were run at room 
temperature for 30 min at 40 V/cm. Such gels enable to detect the intrinsic fluorescence of 
modified oligonucleotides or GFP protein, to stain all nucleic acids with SYBR® Gold 
(Thermo Scientific) and are compatible with total protein GelCode blue stain reagent 
(ThermoFischer). 
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3.6 ONE-POT SYNTHESIS OF OLIGONUCLEOTIDES AND CONJUGATION 
WITH MVIRD2-TAGGED PROTEINS 
The sequential oligonucleotides synthesis and conjugation, with no need of buffer exchange, 
was made possible by the compatibility among amplification, digestion and conjugation. 
Typically, a MOSIC digestion reaction with BseGI is heat inactivated (75 ºC for 20 minutes) 
and slowly cooled down to 37 ºC. The mVirD2 chimeric protein is directly added to the reaction 
and incubated for 1 to 2 hours previous assessment on a 12 % Bis-Tris PAGE gel.  
3.7 PREPARATION OF G-QUADRUPLEX OLIGONUCLEOTIDES 
The stabilization of G-quadruplex structures in the oligonucleotide (IDT) used for signal 
amplification in conditions suitable for the conjugation with the mVirD2-C1 protein was 
optimized. The conjugation buffer was modified by increasing its potassium chloride 
concentration (modified TKM buffer: mTKM: containing 150 mM KCl, 3.5 mM MgCl2, 10% 
glycerol and 50 mM Tris HCl, pH 8.0). Proper folding of secondary structures was enabled by 
heating the sample in mTKM buffer at 95 ºC for 5 minutes in a PCR thermocycler and gradually 
cooled down to 4 ºC at a rate of 0.1 ºC/s. Evaluation of the folding was made by gel 
electrophoresis and peroxidation assay. 
3.8 CONJUGATION SCALE UP AND PURIFICATION OF THE 
OLIGONUCLEOTIDE-PROTEIN BIOSENSOR 
Small scale conjugation reactions were performed similarly to what previously indicated while 
preparative conjugation reactions were performed in a 45 µl volume. The typical reaction 
comprises 22.5 µl of mTKM buffer, 22.5 µg of the fusion protein mVirD2-C1 and folded G4 
oligonucleotides in molar ratios of 1:1 or 2:1 and incubated at 37 ºC for 2 hours. The crude 
reaction was speared in a 10 % native PAGE stained with SYBR® Gold (Thermo Scientific) 
and bands of interest were excised. Gel slices were soaked in TBS 1x buffer supplemented with 
150 mM KCl for 4.5 h at 35°C under constant agitation (300 rpm). Next, the extracts were run 
through a 0.45 μm nylon filter device (VWR) in a bench-top centrifuge (90 sec at 16,800 rcf) 
and assessed for purity by gel electrophoresis. 
3.9 COLORIMETRIC DNAZYME POX ASSAY 
Prior to the experiment, a 4 μM hemin (Sigma-Aldrich) working solution was prepared by 
diluting a freshly thawed stock solution (1 mM in DMSO, stored at -20° C, protected from 
light) with mTKM buffer. Ten μL of this hemin stock solution were mixed with an equal 
volume of folded G-quadruplex oligonucleotides (1.6 μM, if not indicated differently) or gel-
purified mVirD2-C1 DNAzyme conjugates (0.16 μM), respectively, and incubated in the dark 
for 30 min at 25 °C in a PCR thermocycler. At time point 0 of the reaction, 10 μL of freshly 
prepared 20 mM ABTS (Roche) and 3 μL of 3.75 mM H2O2 (Sigma-Aldrich) were added to 
the hemin-DNA mixture and the samples were mixed thoroughly for a few seconds (Figure 
S3A). The final working concentrations were 1.2 μM hemin, 0.5 μM DNA, 6 mM ABTS and 
350 μM H2O2 in either mTKM buffer or, for experiments on gel-purified conjugates, in 1x TBS 
buffer containing 150 mM KCl. Two μL of the reaction mixture were then loaded onto a 
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μDrop™ Plate (Thermo Scientific) and the change of absorbance at 420 nm and 25°C was 
recorded every minute on a Varioskan Lux microplate reader (Thermo Scientific) with a 
measurement time of 250 milliseconds per read. Absorbance data were plotted with GraphPad 
Prism 8 after subtraction of background signal (absorbance in the absence of G-quadruplex 
DNA). 
3.10 BRANCHED RCA IN SOLUTION AND ON DNA NANOSTRUCTURES  
In this specific case, a circular ssDNA (1 ng/μL) serves as template in an RCA reaction primed 
by an oligonucleotide - P1- (100 nM) in a typical reaction mixture (0.5 U/μL Φ29 (Thermo 
Scientific), dNTPs 1 mM each in 1x Φ29 buffer). The branched amplification is triggered by a 
second oligonucleotide species - P2 - (100 nM) complementary to the previously generated 
DNA polymer. Such reaction is generally incubated for 30 minutes at 30 ºC and stopped by 
heat inactivation.  
3.11 PREPARATION OF “READY TO SEQUENCE” LIBRARY AND NEXT 
GENERATION SEQUENCING 
The information-dense DNA fragment generated during the RCA reaction is collected with the 
use of streptavidin functionalized magnetic beads (Thermo Scientific) and used as template for 
a two-step PCR.  
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4 RESULTS AND DISCUSSIONS 
 
4.1 PAPER I 
4.1.1 Φ29 polymerase driven RCA produces mainly dsDNA 
In paper one, we studied the RCA with the aim to optimize the amplification reaction for the 
production of ssDNA oligonucleotides. In such process, we discovered that most of the product 
resulting from long incubations (> 10h) is in the form of dsDNA. This has been proved using 
two different templates, pUC19 and pBluscript II SK(+), on which an RCA reaction is initiated 
from a 3’ end generated by a nicking endonuclease. In such experiment, the product of a 24-
hour amplification – in absence or presence of single-stranded DNA binding proteins (SSBs) - 
is assessed in an agarose gel as is or after treatment with restriction endonucleases. It is pretty 
noticeable how the presence in the reaction mix of SSBs, in this case the T4 gene 32 protein, 
affects the total amount of DNA produced. However, a high molecular weight polymer is still 
noticeable in the gel well. Moreover, the treatment of the RCA product with restriction 
endonuclease in absence of SSBs leads to the predicted digestion pattern of regular dsDNA 
while, in the presence of SSBs, this pattern is absent. Such findings have also been confirmed 
by an additional experiment in which the RCA product generated from the pUC19 template in 
presence of a gradient of SSBs, as for the restriction assay, was combined with the dsDNA 
specific fluorescent dye PicoGreen®. Here it is noticeable how including the T4 gene 32 
protein at a concentration of 100 ng/μL almost abolished the recorded fluorescence.  
4.1.2 T4 gene 32 SSB prevents the formation of dsDNA in RCA 
To investigate if SSBs simply inhibits RCA or rather specifically prevents the formation of 
dsDNA we assessed the product quality of an enzymatically produced 378 bases long 
oligonucleotide with the MOSIC protocol. Seven independent RCA reactions – in presence or 
absence of SSBs - using a nicked minicircle enclosing the oligonucleotide template were 
stopped after 30 minutes, 1, 3, 6, 9, 12, 24 hours. The obtained products were first digested 
with the restriction endonuclease BseGI and size separated on an agarose gel. It was then 
possible to appreciate that the digestion product of reactions incubated in absence of SSBs is 
running, according to the ladder, as a dsDNA of almost 400 bp while in presence of SSBs in 
the reaction most of the digested product is running faster (at the height corresponding to the 
300 bp band of the ladder) as it is ssDNA. Nevertheless, the ethidium bromide is not staining 
with the same efficiency ssDNA and dsDNA therefore it is not possible to compare the 
reactions yield. For this reason, an additional experiment was designed. The same template 
(p378), was used for new RCA reactions in presence or absence of SSBs for up to 72 hours. 
After digestion, a part of the product was assessed on a native agarose gel to determine the 
ssDNA/dsDNA ratio while the second part of the sample was used for total DNA quantification 
in a denaturing PAGE gel stained with SYBR® Gold. The relative band intensity was used to 
determine the amount of total, single-stranded and dsDNA produced at each time point. It is 
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interesting to notice that in absence of SSBs, ssDNA is produced first and later (> 12 hours) 
converted to dsDNA while this is inhibited with SSBs without affecting the reaction yield.  
 
4.2 PAPER II 
4.2.1 Characterization of the self-tagging domain mVirD2 
The Protein VirD2 from Agrobacterium tumefaciens is known to drive the genetic material 
transfer of pathogenic genes in the host cell. In this work we exploited this ability to generate 
a compact self-tagging domain for site specific conjugation of ssDNA to a protein of choice. 
The native protein exhibits two main functions, the N-terminus domain is involved with the 
recognition of the DNA sequence consensus that triggers the nicking coupled with the bond 
formation and a C-terminus helicase capable of unwinding dsDNA. It has also been 
demonstrated that a conserved tyrosine at position 29 is involved in the bond formation with 
the DNA molecule. For those reasons a minimal self-tagging domain was established by 
truncating the protein at the end of the N-terminus domain (amino acid 204) producing a 24.5 
kDa. The tag was produced alone or in fusion with the green fluorescent protein (GFP) and its 
ability to recognize and establish a covalent bond with oligonucleotides was assessed with 
electro mobility shift assays where both nucleic acids and proteins were stained. This first assay 
confirmed that the purified minimal recombinant protein is active in binding the 
oligonucleotide in a dose dependent manner. Moreover, the presence of the GFP did not hinder 
the conjugation. A limitation of the technique itself resides in the reversibility of the 
conjugation reaction that imitates the effective conjugation to env. 40% of the proteins while 
the DNA is entirely bound to proteins if the latter are present in excess. We faced this limitation 
by developing some strategies to increase the conjugation yield by using chemically modified 
oligonucleotides. We observed that 3’ end locked oligonucleotides could safely be incubated 
in a conjugation reaction in presence of exonucleases (3’ to 5’ activity) while the nicked 
byproduct fragment produced in the reaction is degraded. The degradation of this substrate 
reduces the chances for the reverse reaction to happen. A second strategy regards the use of 
phosphorothioate (PS) modified oligonucleotides. In this case, the reverse reaction is 
unfavorable for the charges distribution on the residues involved in the bond.  
4.2.2 Sequential synthesis and conjugation of oligonucleotides 
The main motivation behind the development of this conjugation strategy is to extend the 
capabilities of the previous implemented method for the enzymatic synthesis of 
oligonucleotides combining a conjugation step in a biologically neutral condition. To validate 
this combined protocol, the conjugation was first tested in the RCA restriction enzyme buffer. 
Later, two different pseudogenes were produced enclosing respectively a 103-nucleotide long 
oligonucleotide and two oligonucleotides of 87 and 57 bases. All oligos produced 
enzymatically for conjugation have been elongated at the 5’ sequence with the T1 consensus 
(17 nucleotides long). Different PAGE gels enabled to highlight the different steps of the 
sequential method in respect of the DNA or the protein.  
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4.2.3 Applications of the new conjugation technique 
As a general proof of relevance of the technique a few applications have been proposed. In the 
first case a DNA aptamer generated enzymatically was coupled with a HER2 aptamer. This 
biosensor was proved to associate with the recombinant protein in vitro (in solution or blotted) 
or to find application in sating biological samples. As a continuation of the project the protein 
was also transiently expressed extracellularly as chimera of the PDGF receptor’s 
transmembrane domain. The incubation of a labeled oligonucleotide with the cells in PBS 
buffer supplemented with magnesium enabled to label the cells membranes. Another proof of 
concept was to explore the possibility to use mVirD2 DNA binding tag to direct transcription 
activator with the use of oligonucleotides pre-complexed to a luciferase plasmid.  
 
4.3 PAPER III 
4.3.1 Generation of a DNA-protein conjugate for antigen detection 
In this work a specific application suggested in the previous paper was further explored: the 
construction of a biosensor for the detection of the toxic algae Alexandrium minutum. In this 
case the oligonucleotide is used as signal propagation tool by mean of the intrinsic capabilities 
of G rich oligonucleotides to operate as peroxidase-like DNAzymes while the mVirD2 domain 
was designed, produced and purified in fusion with a nanobody with a yield of 30-50 mg/L. 
The ability of the fusion nanobody to bind its antigen was assessed by immunostaining against 
A. minutum cells and detected with an anti His-tag secondary antibody. While the ssDNA 
binding activity was validated before with the use of electromobility shift assays, the biosensor 
was produced substantially as before, exception made for the oligonucleotide’s secondary 
structure that needed a folding step and a buffer supplementation with further KCl (150 mM) 
to stabilize the G-quadruplex structure. Such deviations did not impact the conjugation ability 
furthermore the presence of the bound protein did not affect the selected DNAzyme 
peroxidation activity. To obtain a maximal response a set of previously validated DNAzymes, 
with the wanted function, were tested as for their ability to retain the secondary structure after 
conjugation (EMSA) and to induce a peroxidation (ABTS-H2O2 system) once complexed with 
hemin. The selected sequence T2-CatG4 is a fusion of the mVirD2 PS modified binding 
domain (T2) connected through a 3 or 12 nucleotide linker with the DNAzyme sequence 
(CatG4). The linker purpose is to reduce interactions between the protein and the DNAzyme 
even though a direct comparison of the different lengths did not influence the activity in ABTS 
oxidation or conjugation therefore we chose to conduct further experiments with T2-CatG4a 
(12 nucleotides spacer).  
4.3.2  Production scale up and validation 
The main challenge of this project was the production of enough conjugate for the validation. 
For this reason, a novel strategy is here proposed. Large scale reactions were incubated as 
before in a modified buffer (150 mM KCl) and verified by EMSA. To validate the activity of 
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the biosensor it was necessary to remove the unreacted oligonucleotides and proteins. For this 
purpose, the most effective strategy was to select the right conjugation product using a 
preparative PAGE gel. The so obtained biosensor was used in immune staining to check if the 
oligonucleotide hindered the antigen recognition or impaired the specificity for the target. 
Finally, the purified biosensor was used in an ELISA assay and absorbance of the oxidized 
ABTS substrate was measured a t 420nm. The recorded signal revealed a dependency on the 
cell number used on the assay that is clearly above the background signal.   
 
4.4 PAPER IV 
4.4.1 Design of a DNA-based approach for the detection of the organization 
of proteins of interest 
In the present work we designed a strategy to collect information from the reciprocal 
localization of proteins of interest (POI). The amplification reaction relies on a rolling circle 
amplification of a circular ssDNA template embedding a unique molecular identifier (ID) that 
was produced by annealing to a padlock oligonucleotide and enzymatic ligation. Such a 
template is able to produce a long homo-polymer propagating locally the distinctive ID. The 
polymer is designed in such a way to enable hybridizations with a second species of uniquely 
identified oligonucleotides linked to protein binders. Those oligonucleotides can be extended, 
in the same reaction, on the polymer template thus providing a fusion product bearing the two 
IDs sequences (ID1 and ID2). The ability of producing such information-rich fragments, 
retrieving the embedded information and giving an interpretation to the collected data was 
assessed in vitro. In first place an RCA reaction is triggered with the use of the oligonucleotide 
P1. The presence of biotinylated P2 oligos enables the generation of the fusion strand and its 
selection from the mass of amplification product. A first step of enzymatic restriction enables 
to reduce the complexity of the sample and select with more precision the fusion product with 
streptavidin coated magnetic beads. The collected product is amplified by PCR for increasing 
the number of molecules and including the necessary adapters for the sequencing part.  
4.4.2 Proof of concept and validation of the proposed workflow 
Such described design was first tested in vitro on streptavidin-coated magnetic beads. This 
experiment proved that, once correctly designed, the oligonucleotides involved in the reaction 
are able to 1) generate an RCA product and 2) promote the fusion of DNA molecules - 
including unique molecular identifiers – during the same reaction. The information-rich 
fragment was at first PCR amplified and sequenced. Bulk sequencing (Sanger) of the 
information-rich pool of molecules highlighted the structure of the desired barcode. Similar 
experiments were reproduced in solution or on DNA nanostructures and modified in such a 
way to produce an NGS compatible library via a 2-step PCR protocol. DNA was sequenced 
with an Illumina Nextseq instrument. Analysis showed the possibility to recover single 
ID1/ID2 combinations and to reconstruct a connection network.  
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Next steps to prove the validity of the method will involve the use of fixed cell lines with known 
expression levels for the two antigens of choice (HER2 and EGFR). Different cell lines have 
been screened with the PLA method as a comparison method.  
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5 CONCLUSIONS 
Historically, the miniaturization of devices in biomedicine aimed to reduce the costs by 
lowering the consumption of limiting reagents. A macroscopic example of this could be the 
invention of hand micropipettes that enabled the development of molecular biology. A similar 
motivation also underlined the development of DNA nanotechnology now more than 20 years 
ago even though researchers are still looking for a “killing” application of the method for which 
the metaphor of the colossus with clay feet would give a good description. The capability of 
investigating biological reactions at the nanoscale would provide us precious information to 
decipher physiological and pathological phenomena. However, too many intrinsic limitations 
of nanostructures - i.e. construction, stability, functionalization - often lead to an increasing 
level of complexity to solve problems resulting in an overcomplication of the strategy. More 
fundamental work is indeed needed to extend the applicability of such tools. 
The overall aim of the papers presented here is to take a step back and work on the improvement 
of the basic building materials – DNA oligonucleotides (Paper I), DNA-protein conjugates 
(Paper II). As earlier discussed, there is a growing need of high-quality DNA for precision 
application not only connected to the construction of DNA nanostructures but also for example 
in the production of nucleic acids-based therapeutics or genome editing applications. In this 
thesis we proved that limitations of traditional solid-state chemical synthesis can be overcome 
with the use of enzymatic strategies. Such strategies have room for improvement and will most 
probably become a competitive alternative in the next decade. The ability of exploiting 
enzymatic systems to build biomolecules enables the integration of several modules that are 
traditionally separated as, for instance, proved with the combination of synthesis and targeted 
conjugation to proteins.  
As a secondary aim of this thesis, the outcomes of the new tools provided were leveraged to be 
applied for the solutions of problems. The trait d’union with this section is represented by the 
possibility of using the minimal unit of a DNA-protein conjugate as a biosensor (Paper III). In 
this case, we wanted to prove how environmental point of analysis devices could greatly benefit 
from the modular assembly, a key concept in nanotechnology, to produce consistent, cost-
effective and time saving biosensors. 
The same technology also enabled the production of monomeric binders conjugated with DNA 
in a 1:1 ratio. They have been used in the last presented manuscript (Paper IV). Starting from 
this point we wanted to prove that it is indeed possible to (a) locally grow a DNA amplification 
product able to (b) create a bipartite network among biomolecules of interest encoding (c) a 
reciprocal spatial organization in a couple of DNA barcodes. Even though a minimal proof of 
concept of the approach has been provided, the so far obtained data look encouraging. Further 
work is indeed necessary to fully validate the methodological approach and its capabilities. 
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